By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

National Institute of Allergy And Infectious Diseases (NIAID) 

31 Center Drive MSC 2520
Building 31, Room 7A-50
Bethesda  Maryland  20892-2520  U.S.A.
Phone: 301-496-5717 Fax:


SEARCH JOBS


Industry
Healthcare


Collaborations

MedImmune, LLC 

MedImmune 





Company News
J. Craig Venter Institute Key Member Of Team Awarded Up To A 5-Year, $23 Million Contract From National Institute of Allergy And Infectious Diseases (NIAID) For Renewal Of Bioinformatics Resource Centers For Infectious Diseases Viral Project 11/11/2014 9:59:19 AM
Soligenix (SNGX) Awarded National Institute of Allergy And Infectious Diseases (NIAID) Contract Valued Up To $24.7 Million 9/19/2014 6:25:08 AM
Biocryst Pharmaceuticals (BCRX) Receives Additional National Institute of Allergy And Infectious Diseases (NIAID) Funding For Manufacture And Development Of BCX4430 To Treat Hemorrhagic Virus Diseases 9/18/2014 11:20:04 AM
Biocryst Pharmaceuticals (BCRX) Receives Additional National Institute of Allergy And Infectious Diseases (NIAID) Funding To Advance Development Of BCX4430 To Treat Hemorrhagic Fever Virus Diseases 8/13/2014 7:20:58 AM
Soligenix (SNGX) Receives Additional National Institute of Allergy And Infectious Diseases (NIAID) Funding To Advance Development Of OrbeShield™ In GI ARS 8/1/2014 7:14:57 AM
Potent HIV Antibody Research Has Opened Up Possibilities For HIV Prevention, Treatment, National Institute of Allergy And Infectious Diseases (NIAID) And Columbia University Study 3/4/2014 6:39:29 AM
Vitamin A Deficiency Promotes Type 2 Barrier Immunity, National Institute of Allergy And Infectious Diseases (NIAID) Reveals 1/24/2014 6:47:43 AM
Vivaldi Biosciences Inc. Signs Cooperative Research And Development Agreement (CRADA) With National Institute of Allergy And Infectious Diseases (NIAID) To Develop Live Attenuated Influenza Vaccine Against Influenza H7N9 1/21/2014 9:23:08 AM
Biocryst Pharmaceuticals (BCRX) Receives Additional National Institute of Allergy And Infectious Diseases (NIAID) Funding To Advance Development Of BCX4430 To Treat Marburg Virus Disease 12/30/2013 8:30:42 AM
National Institute of Allergy And Infectious Diseases (NIAID) And National Institutes of Health (NIH) Researchers Identify Resistant Genetic Marker To Key Malaria Drug 12/20/2013 7:46:38 AM
12345678910...
//-->